EE200100324A - Meetod aktiivse lümfotoksiin-beeta retseptori immunoglobuliinsete kimäärsete valkude kõrgtasemel ekspressiooniks ja puhastamiseks - Google Patents

Meetod aktiivse lümfotoksiin-beeta retseptori immunoglobuliinsete kimäärsete valkude kõrgtasemel ekspressiooniks ja puhastamiseks

Info

Publication number: EE200100324A
Authority: EE; Estonia
Prior art keywords: purification; level expression; chimeric proteins; beta receptor; lymphotoxin beta
Prior art date: 1998-12-17

Application number

EEP200100324A

Other languages

English (en)

Inventor

L. Browning Jeffrey

Miatkowski Konrad

Meier Werner

Original Assignee

Biogen, Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-17

Filing date

1999-12-16

Publication date

2002-10-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22345666&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200100324(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-12-16 Application filed by Biogen, Inc. filed Critical Biogen, Inc.

2002-10-15 Publication of EE200100324A publication Critical patent/EE200100324A/et

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Wood Science & Technology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Biotechnology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Cell Biology (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Toxicology (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Biomedical Technology (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Compounds Of Unknown Constitution (AREA)

EEP200100324A 1998-12-17 1999-12-16 Meetod aktiivse lümfotoksiin-beeta retseptori immunoglobuliinsete kimäärsete valkude kõrgtasemel ekspressiooniks ja puhastamiseks EE200100324A (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US11275298P	1998-12-17	1998-12-17
PCT/US1999/029873 WO2000036092A2 (en)	1998-12-17	1999-12-16	METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-β RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION

Publications (1)

Publication Number	Publication Date
EE200100324A true EE200100324A (et)	2002-10-15

Family

ID=22345666

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP200100324A EE200100324A (et)	1998-12-17	1999-12-16	Meetod aktiivse lümfotoksiin-beeta retseptori immunoglobuliinsete kimäärsete valkude kõrgtasemel ekspressiooniks ja puhastamiseks

Country Status (27)

Country	Link
US (3)	US7585946B2 (et)
EP (3)	EP3006563A1 (et)
JP (4)	JP4878676B2 (et)
KR (3)	KR20020013482A (et)
CN (2)	CN100387708C (et)
AT (1)	ATE536372T1 (et)
AU (2)	AU777232B2 (et)
BR (1)	BR9916325B1 (et)
CA (1)	CA2354539A1 (et)
CY (1)	CY1117003T1 (et)
CZ (1)	CZ20012156A3 (et)
DK (2)	DK1141248T3 (et)
EA (1)	EA005270B1 (et)
EE (1)	EE200100324A (et)
ES (1)	ES2554482T5 (et)
HK (1)	HK1223398A1 (et)
HU (1)	HUP0200064A2 (et)
IL (3)	IL143670A0 (et)
IS (1)	IS5959A (et)
NO (1)	NO20012991L (et)
NZ (3)	NZ549623A (et)
PT (1)	PT2374872E (et)
SG (1)	SG123531A1 (et)
SI (1)	SI2374872T2 (et)
SK (1)	SK8552001A3 (et)
TR (2)	TR200504220T2 (et)
WO (1)	WO2000036092A2 (et)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5925351A (en)	1995-07-21	1999-07-20	Biogen, Inc.	Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
US7060667B1 (en)	1998-01-30	2006-06-13	Biogen Idec Ma, Inc.	Treatment of follicular lymphomas using inhibitors of the LT pathway
SK4662001A3 (en) *	1998-10-09	2001-11-06	Biogen Inc	Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway
US20020168367A1 (en) *	2000-04-28	2002-11-14	Planet Biotechnology Incorporated	Novel immunoadhesins for treating and preventing viral and bacterial diseases
ATE442386T1 (de)	2000-04-28	2009-09-15	Planet Biotechnology Inc	Immunoadhesin zur impfung gegen rhinovirus
ATE325865T1 (de) *	2001-01-16	2006-06-15	Regeneron Pharma	Isolierung von sezernierte proteine exprimierenden zellen
US20090137416A1 (en)	2001-01-16	2009-05-28	Regeneron Pharmaceuticals, Inc.	Isolating Cells Expressing Secreted Proteins
WO2004058191A2 (en) *	2002-12-20	2004-07-15	Biogen Idec Ma Inc.	Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof
AU2003303394B2 (en)	2002-12-23	2009-02-19	Bristol-Myers Squibb Company	Product quality enhancement in mammalian cell culture processes for protein production
CA2511520A1 (en)	2002-12-23	2004-07-15	Bristol-Myers Squibb Company	Mammalian cell culture processes for protein production
WO2005024012A1 (en) *	2003-09-11	2005-03-17	Novozymes A/S	Increased expression of a modified polypeptide
AU2004309114A1 (en) *	2003-12-23	2005-07-14	Laboratoires Serono Sa	Process for the production of tumor necrosis factor-binding proteins
US20110038854A1 (en) *	2006-03-30	2011-02-17	University Of Medicine And Dentistry Of New Jersey	Strategy for homo- or hetero-dimerization of various proteins in solution and in cell
JP5298021B2 (ja)	2006-10-12	2013-09-25	ジェネンテック，インコーポレイテッド	リンホトキシン−αに対する抗体
AU2007311052B2 (en)	2006-10-20	2014-01-16	Biogen Idec Ma Inc.	Treatment of demyelinating disorders with soluble lymphotoxin-beta-receptor
US8338376B2 (en) *	2006-10-20	2012-12-25	Biogen Idec Ma Inc.	Compositions comprising variant LT-B-R-IG fusion proteins
WO2008112325A2 (en) *	2007-03-15	2008-09-18	Biogen Idec Ma Inc.	Treatment of autoimmune disorders
TW200902708A (en)	2007-04-23	2009-01-16	Wyeth Corp	Methods of protein production using anti-senescence compounds
CN102239177A (zh) *	2008-02-29	2011-11-09	比奥根艾迪克Ma公司	纯化的免疫球蛋白融合蛋白及其纯化方法
US9540426B2 (en)	2009-10-06	2017-01-10	Bristol-Myers Squibb Company	Mammalian cell culture processes for protein production
KR101828624B1 (ko)	2010-04-26	2018-02-12	노파르티스 아게	개선된 세포 배양 방법
WO2012176158A1 (en) *	2011-06-24	2012-12-27	Dr. Reddy's Laboratories Limited	Purification of chimeric protein
KR101454316B1 (ko)	2011-08-17	2014-10-27	한화케미칼 주식회사	활성형 ＴＮＦＲ-Ｆｃ 융합 단백질을 제조하는 방법
WO2014062535A1 (en)	2012-10-15	2014-04-24	Bristol-Myers Squibb Company	Mammalian cell culture processes for protein production
TWI745610B (zh)	2012-11-14	2021-11-11	美商再生元醫藥公司	重組細胞表面捕捉蛋白質
SG10201913567QA (en)	2015-06-30	2020-02-27	Sanford Burnham Med Res Inst	Btla fusion protein agonists and uses thereof
KR101936049B1 (ko)	2015-10-15	2019-01-08	(주)알테오젠	IgG Fc 도메인을 가지는 융합 단백질의 생산방법
CN105400721A (zh) *	2015-12-11	2016-03-16	湖南农业大学	一种快速筛选具有抗菌活性芽孢杆菌的方法

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2906096A (en)	1953-12-14	1959-09-29	Pacific Ind Mfg Co	Precision control system for press brakes or the like
WO1991000347A1 (en)	1989-07-04	1991-01-10	Novo Nordisk A/S	Method of producing proteins with fviii activity and/or fviii derivatives
US5605690A (en) *	1989-09-05	1997-02-25	Immunex Corporation	Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor
ES2157889T3 (es) *	1990-06-27	2001-09-01	Biogen Inc	Linfotoxina complejada de superficie.
US5670149A (en) *	1990-06-27	1997-09-23	Biogen, Inc.	Lymphotoxin-β, Lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof
US7030080B2 (en) *	1990-06-27	2006-04-18	Biogen, Inc.	Lymphotoxin-β, lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof
ATE185601T1 (de)	1990-07-10	1999-10-15	Cambridge Antibody Tech	Verfahren zur herstellung von spezifischen bindungspaargliedern
NZ260103A (en) *	1990-11-30	1996-10-28	Bio Technology General Corp	Somatotropin with alterations in the alpha-helix-1 region
US5656272A (en) *	1991-03-18	1997-08-12	New York University Medical Center	Methods of treating TNF-α-mediated Crohn's disease using chimeric anti-TNF antibodies
IE922437A1 (en) *	1991-07-25	1993-01-27	Idec Pharma Corp	Recombinant antibodies for human therapy
US5447851B1 (en) *	1992-04-02	1999-07-06	Univ Texas System Board Of	Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells
US5643570A (en) *	1992-05-19	1997-07-01	Xoma Corporation	BPI-immunoglobulin fusion proteins
CA2123593C (en) *	1992-09-15	2000-03-14	Craig A. Smith	Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists
WO1994006478A1 (en)	1992-09-22	1994-03-31	Medin Corporation	A system for securing medical tools for sterilization
DK0672142T3 (da)	1992-12-04	2001-06-18	Medical Res Council	Multivalente og multispecifikke bindingsproteiner samt fremstilling og anvendelse af disse
US5691196A (en) *	1992-12-31	1997-11-25	American Cyanamid Company	Recombinant nucleic acid containing a response element
US5429746A (en) *	1994-02-22	1995-07-04	Smith Kline Beecham Corporation	Antibody purification
US5856179A (en)	1994-03-10	1999-01-05	Genentech, Inc.	Polypeptide production in animal cell culture
US5726039A (en) *	1994-07-21	1998-03-10	Yissum Research Development Co. Of The Hebrew University Of Jerusalem	Vectors and transformed host cells for recombinant protein production at reduced temperatures
US5541087A (en) *	1994-09-14	1996-07-30	Fuji Immunopharmaceuticals Corporation	Expression and export technology of proteins as immunofusins
US6312691B1 (en) *	1996-01-26	2001-11-06	Jeffrey L. Browning	Lymphotoxin-α/β complexes and anti-lympotoxin-β receptor antibodies as anti-tumor agents
US5721121A (en) *	1995-06-06	1998-02-24	Genentech, Inc.	Mammalian cell culture process for producing a tumor necrosis factor receptor immunoglobulin chimeric protein
US5705364A (en)	1995-06-06	1998-01-06	Genentech, Inc.	Mammalian cell culture process
US5925351A (en) *	1995-07-21	1999-07-20	Biogen, Inc.	Soluble lymphotoxin-β receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
US6291207B1 (en) *	1995-07-28	2001-09-18	Northwestern University	Herpes virus entry receptor protein
JP4306813B2 (ja)	1995-09-19	2009-08-05	アスビオファーマ株式会社	動物細胞の新規培養方法
JP2000510113A (ja) *	1996-05-08	2000-08-08	エフ・ホフマン―ラロシュアーゲー	ＴＮＦＲ―Ｉｇによる喘息の治療
US6040560A (en) *	1996-10-22	2000-03-21	Philip Morris Incorporated	Power controller and method of operating an electrical smoking system
US7255854B1 (en) *	1996-10-25	2007-08-14	Biogen, Inc.	Use of lymphotoxin-β receptor blocking agents for the treatment of antibody mediated immunological diseases
WO1998017313A2 (en) *	1996-10-25	1998-04-30	Biogen, Inc.	Soluble lymphotoxin-beta receptors, anti-lymphotoxin receptor antibodies, and anti-lymphotoxin ligand antibodies as therapeutic agents for the treatment of immunological diseases
JP2001502912A (ja) *	1996-10-30	2001-03-06	ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド	ヒト腫瘍壊死因子レセプター―ライク２
EP0948543A1 (en) *	1996-12-12	1999-10-13	Genentech, Inc.	Hvem polypeptides and uses thereof
US6221608B1 (en) *	1997-01-22	2001-04-24	Ortho Pharmaceutical Corporation	Methods for identifying erythropoietin receptor binding protein
US7060667B1 (en) *	1998-01-30	2006-06-13	Biogen Idec Ma, Inc.	Treatment of follicular lymphomas using inhibitors of the LT pathway
AU763513B2 (en) *	1998-04-16	2003-07-24	Genentech Inc.	Secretion of glycosylated proteins using a tissue plasminogen activator pro-sequence
DE69929198T2 (de)	1998-05-29	2006-08-10	Genentech, Inc., South San Francisco	Zellkulturverfahren für die produktion von glycoproteinen
SK4662001A3 (en) *	1998-10-09	2001-11-06	Biogen Inc	Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway
US7294481B1 (en)	1999-01-05	2007-11-13	Immunex Corporation	Method for producing recombinant proteins
US9086881B2 (en)	2012-06-29	2015-07-21	Intel Corporation	Mechanism for facilitating write tracking for following data eye movements across changing thermal conditions in memory systems

1999
- 1999-11-16 TR TR2005/042202005/04220T patent/TR200504220T2/xx unknown
- 1999-12-16 ES ES10011212T patent/ES2554482T5/es not_active Expired - Lifetime
- 1999-12-16 IL IL14367099A patent/IL143670A0/xx unknown
- 1999-12-16 HU HU0200064A patent/HUP0200064A2/hu unknown
- 1999-12-16 EP EP15183033.8A patent/EP3006563A1/en not_active Withdrawn
- 1999-12-16 CN CNB998156957A patent/CN100387708C/zh not_active Expired - Fee Related
- 1999-12-16 KR KR1020017007475A patent/KR20020013482A/ko not_active Ceased
- 1999-12-16 EA EA200100670A patent/EA005270B1/ru not_active IP Right Cessation
- 1999-12-16 NZ NZ549623A patent/NZ549623A/en not_active IP Right Cessation
- 1999-12-16 AU AU23644/00A patent/AU777232B2/en not_active Ceased
- 1999-12-16 JP JP2000588341A patent/JP4878676B2/ja not_active Expired - Lifetime
- 1999-12-16 EE EEP200100324A patent/EE200100324A/et unknown
- 1999-12-16 KR KR1020077017658A patent/KR20070091227A/ko not_active Ceased
- 1999-12-16 PT PT100112127T patent/PT2374872E/pt unknown
- 1999-12-16 TR TR2001/01703T patent/TR200101703T2/xx unknown
- 1999-12-16 DK DK99967350.2T patent/DK1141248T3/da active
- 1999-12-16 NZ NZ538599A patent/NZ538599A/en not_active IP Right Cessation
- 1999-12-16 WO PCT/US1999/029873 patent/WO2000036092A2/en not_active Ceased
- 1999-12-16 KR KR1020067009941A patent/KR100732934B1/ko not_active Expired - Fee Related
- 1999-12-16 EP EP10011212.7A patent/EP2374872B2/en not_active Expired - Lifetime
- 1999-12-16 CA CA002354539A patent/CA2354539A1/en not_active Abandoned
- 1999-12-16 BR BRPI9916325-0A patent/BR9916325B1/pt not_active IP Right Cessation
- 1999-12-16 DK DK10011212.7T patent/DK2374872T4/en active
- 1999-12-16 SG SG200200026A patent/SG123531A1/en unknown
- 1999-12-16 EP EP99967350A patent/EP1141248B1/en not_active Expired - Lifetime
- 1999-12-16 CZ CZ20012156A patent/CZ20012156A3/cs unknown
- 1999-12-16 NZ NZ529276A patent/NZ529276A/en active IP Right Revival
- 1999-12-16 AT AT99967350T patent/ATE536372T1/de active
- 1999-12-16 SK SK855-2001A patent/SK8552001A3/sk unknown
- 1999-12-16 CN CNA2008100903968A patent/CN101289512A/zh active Pending
- 1999-12-16 SI SI9931079T patent/SI2374872T2/sl unknown
2001
- 2001-01-23 US US09/767,370 patent/US7585946B2/en not_active Expired - Fee Related
- 2001-05-31 IS IS5959A patent/IS5959A/is unknown
- 2001-06-15 NO NO20012991A patent/NO20012991L/no not_active Application Discontinuation
2005
- 2005-01-07 AU AU2005200042A patent/AU2005200042B2/en not_active Ceased
2009
- 2009-08-17 US US12/542,614 patent/US8283138B2/en not_active Expired - Fee Related
2010
- 2010-03-30 JP JP2010079856A patent/JP2010158252A/ja not_active Withdrawn
- 2010-05-11 IL IL205698A patent/IL205698A/en not_active IP Right Cessation
2012
- 2012-07-19 US US13/553,604 patent/US8709759B2/en not_active Expired - Fee Related
2013
- 2013-02-12 JP JP2013024500A patent/JP5777171B2/ja not_active Expired - Lifetime
- 2013-12-01 IL IL229738A patent/IL229738A0/en unknown
2014
- 2014-09-12 JP JP2014186243A patent/JP2014239697A/ja not_active Withdrawn
2015
- 2015-11-26 CY CY20151101065T patent/CY1117003T1/el unknown
2016
- 2016-10-11 HK HK16111728.8A patent/HK1223398A1/en unknown

Also Published As

Publication number	Publication date
EP2374872A3 (en)	2011-10-19
SG123531A1 (en)	2006-07-26
CY1117003T1 (el)	2017-04-05
SI2374872T2 (sl)	2019-05-31
EA005270B1 (ru)	2004-12-30
US20020039580A1 (en)	2002-04-04
KR20070091227A (ko)	2007-09-07
JP4878676B2 (ja)	2012-02-15
SK8552001A3 (en)	2001-12-03
WO2000036092A3 (en)	2000-11-23
WO2000036092A2 (en)	2000-06-22
EP3006563A1 (en)	2016-04-13
IS5959A (is)	2001-05-31
PT2374872E (pt)	2015-12-09
DK2374872T3 (en)	2015-12-14
NZ538599A (en)	2007-11-30
KR100732934B1 (ko)	2007-06-29
EA200100670A1 (ru)	2001-12-24
CA2354539A1 (en)	2000-06-22
US20130196376A1 (en)	2013-08-01
JP2003517277A (ja)	2003-05-27
US8709759B2 (en)	2014-04-29
AU2005200042B2 (en)	2008-05-01
EP2374872A2 (en)	2011-10-12
CN101289512A (zh)	2008-10-22
TR200101703T2 (tr)	2002-05-21
AU2364400A (en)	2000-07-03
PL348816A1 (en)	2002-06-17
US8283138B2 (en)	2012-10-09
BR9916325B1 (pt)	2011-06-28
DK2374872T4 (en)	2019-04-23
CN100387708C (zh)	2008-05-14
JP5777171B2 (ja)	2015-09-09
KR20060084860A (ko)	2006-07-25
IL143670A0 (en)	2002-04-21
AU777232B2 (en)	2004-10-07
EP2374872B1 (en)	2015-11-25
TR200504220T2 (tr)	2007-04-24
EP2374872B2 (en)	2019-02-20
AU2005200042A1 (en)	2005-02-03
HK1223398A1 (en)	2017-07-28
EP1141248A2 (en)	2001-10-10
CN1333819A (zh)	2002-01-30
HUP0200064A2 (en)	2002-05-29
NZ549623A (en)	2008-05-30
JP2010158252A (ja)	2010-07-22
ES2554482T3 (es)	2015-12-21
US7585946B2 (en)	2009-09-08
BR9916325A (pt)	2001-10-02
NZ529276A (en)	2005-03-24
NO20012991L (no)	2001-08-17
SI2374872T1 (sl)	2016-03-31
US20100136625A1 (en)	2010-06-03
IL205698A (en)	2015-11-30
IL229738A0 (en)	2014-01-30
KR20020013482A (ko)	2002-02-20
CZ20012156A3 (cs)	2001-09-12
WO2000036092A9 (en)	2002-08-22
JP2014239697A (ja)	2014-12-25
DK1141248T3 (da)	2012-03-12
HK1038244A1 (en)	2002-03-08
NO20012991D0 (no)	2001-06-15
JP2013116118A (ja)	2013-06-13
ES2554482T5 (es)	2019-07-18
ATE536372T1 (de)	2011-12-15
EP1141248B1 (en)	2011-12-07

Publication	Publication Date	Title
EE200100324A (et)	2002-10-15	Meetod aktiivse lümfotoksiin-beeta retseptori immunoglobuliinsete kimäärsete valkude kõrgtasemel ekspressiooniks ja puhastamiseks
DE69528128D1 (de)	2002-10-17	Rekombinante Chimäre Proteine und Verfahren zur deren Verwendung
NO994998D0 (no)	1999-10-14	Fusjonsproteiner
EE9600015A (et)	1997-10-15	Meetod ja seade pehmete bioloogiliste kudede omavõnkumise registreerimiseks - müomeeter
DK0921395T3 (da)	2003-07-07	Assays til måling af proteinfragmenter i biologiske medier
KR950700779A (ko)	1995-02-20	단백질의 정제방법(Protein purification)
KR950700414A (ko)	1995-01-16	사람 인터루킨-4에 대한 사람화 모노클로날 항체의 클로닝 및 발현(Cloning and expression of humanized monoclonal antibodies against human interleukin-4)
BR9704641A (pt)	1998-06-09	Sistema de expressão de antígenos heterólogos como proteínas de fusão
NO20025354D0 (no)	2002-11-08	Pattedyr-reseptorproteiner; beslektede reagenser og fremgangsmÕter
DK160128C (da)	1991-07-08	Apparat til destruering af mikroorganismer ved bestraaling med ultraviolet lys.
CY1109093T1 (el)	2014-07-02	Πρωτεϊνες των υποδοχεων θηλαστικων, σχετικα αντιδραστηρια και σχετικες μεθοδοι
DE69520340D1 (de)	2001-04-19	Apparat und Methode zur Chipausbeuteermittlung
NO993424D0 (no)	1999-07-12	Fremgangsmåte til selektiv nedbrytning av melkeprotein i naervaer av andre melkeproteiner
ATE414417T1 (de)	2008-12-15	Translations-kontrollelemente für proteinexpression mit hoher ausbeute in den plastiden von höheren pflanzen und verfahren zu deren verwendung
DE69828154D1 (de)	2005-01-20	Anti-alphavbeta3 humanizierte monoklonale antikörper
DK0749481T3 (da)	1999-06-14	Humaniserede monoklonale antistoffer mod human interleukin-4
DE69511132D1 (de)	1999-09-09	Verfahren und System zum Steuern der Tonerkonzentration
DK0912107T3 (da)	2008-01-07	Fremgangsmåde til reducering af nedbrydeligheden af dyrefoderprotein
EP0711992A3 (en)	1997-04-16	Method for determining a fluorescent substance and method for determining enzyme activity
EP0556320A4 (en)	1994-11-23	Monoclonal antibodies to hepatitis c virus and method for using same
DK0785281T3 (da)	2004-09-06	Fremgangsmåde til genetisk differentiering af humlesort
ITBO960293A0 (it)	1996-05-31	Metodo per il controllo dei rifornimenti di carburante e relativa apparecchiatura.
EE200000058A (et)	2000-10-16	Meetod kristalliliste ainete puhastamiseks
DE69836971D1 (de)	2007-03-15	Methode und apparat zur vorhersage von funktionellen proteindomänen, methode zur verbesserung der proteinfunktion, sowie funktionell verbessertes protein
EE9600101A (et)	1998-04-15	Vahend ja meetod DNA nukleotiidide järjestuse määramiseks laserspektroskoopia abil

Legal Events

Date	Code	Title	Description
2005-10-17	HC1A	Change of owner name